Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ghada Mohammed AboelFadl | UNKNOWN |
| Abualauon Elbiblawy | UNKNOWN |
Not provided
Not provided
Not provided
To compare the efficacy of intra-articular administration of neostigmine versus ketamine as adjuvant analgesics after knee arthroscopy.
Arthroscopic knee surgery is commonly performed as an outpatient procedure and is often associated with postoperative pain. Intraarticular (IA) local anesthetics (LA) are often used for prevention of pain after arthroscopic knee surgery; however, the degree of postoperative pain varies. In an effort to find the ideal regime for sufficient, long-lasting postoperative analgesia, many different drugs, including opioids, nonsteroidal anti-inflammatory drugs, ketamine, clonidine, and neostigmine, have been added to the IA LAs The investigators designed this study to compare the efficacy of intra-articular administration of neostigmine versus ketamine as adjuvant analgesics after knee arthroscopy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neostigmine group | Active Comparator | At the end of the surgery patients receive 0.5mg/dose neostigmine +18ml 0.25%bupivacaine in a total volume of 20 ml. |
|
| ketamine group | Active Comparator | At the end of the surgery patients receive 0.5 mg/kg ketamine+18ml 0.25%bupivacaine in a total volume of 20 ml. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neostigmine | Drug | patient receive 0.5mg/dose neostigmine +18ml 0.25%bupivacaine in a total volume of 20 ml. |
|
| Measure | Description | Time Frame |
|---|---|---|
| postoperative analgesic consumption | assessment of each patient on his bed at inpatient ward every 4 hours over a 36-hour period | 36 hours postoperative the total consumption of analgesics in the first 36h postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative visual analogue pain scale (VAS) | assessment of each patient on his bed at inpatient ward every 4 hours over a 36-hour period | 36 hours postoperative |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Abualauon Elbiplaoy, lectural of anesthesia | Assiut University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Assiut university hospitals | Asyut | Assiut Governorate | Egypt, 715715 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D009388 | Neostigmine |
| D007649 | Ketamine |
| ID | Term |
|---|---|
| D050338 | Phenylammonium Compounds |
| D000644 | Quaternary Ammonium Compounds |
| D000588 | Amines |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
| ketamine | Drug | patient receive 0.5 mg/kg ketamine+18ml 0.25%bupivacaine in a total volume of 20 ml. |
|
|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D009861 |
| Onium Compounds |
| D003510 | Cyclohexanes |
| D003516 | Cycloparaffins |
| D006840 | Hydrocarbons, Alicyclic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |